SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUMs Q3 resultsrecord revenue and its first adjusted-EBITDA-profitable quarterare driving discussion, with traders highlighting Quake AI and Northern Data growth. The reaction is mixed: bulls point to the results and short interest, while skeptics question cash needs, financing, and potential delays to planned data-center capacity.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,959,453.18587388 with 16,959,453.64420722 in circulation. The last known price of Zcash is 1,033.61575403 USD and is down -11.66 over the last 24 hours. It is currently trading on 670 active market(s) with $1,322,935,861.71 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcash is drawing attention for a sharp, volatile pullback after a strong rally, with traders debating whether it reflects profit-taking and an unwind or broader crypto-market weakness. Bearish posts call the move a rug pull and expect further losses, while bullish traders view the dip as a buying opportunity and continue accumulating.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis quarterly results and outlook are driving debate, with traders focused on a steep revenue miss and guidance below expectations as they question the companys valuation and commercialization timeline. Others point to technical progress and government support, while some are trading a rebound after the selloff.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors Q3 call reaffirmed confidence in deramiocel and said its FDA application for Duchenne muscular dystrophy is in final review ahead of the Nov. 22 decision, keeping the approval outcome as the dominant focus. Many traders read managements comments and launch preparations as encouraging, while others stress that approval is uncertain and a rejection remains a major risk.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias selloff and rebound are being debated amid reports about CEO Jensen Huangs alleged relationship with someone described as linked to Chinese intelligence, raising trader concerns about leadership, investigations and chip-export exposure. The Baird downgrade and questions about AI spending add to caution, while bulls argue that CoreWeaves results support continued demand and view the pullback as temporary noise.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists Q3 results and earnings call drew attention for its shift toward recurring memory-technology licensing revenue, with traders also parsing the CEOs comments as a possible hint of a future SK Hynix deal. Many were bullish on the stronger financial footing and expected future payments, while others noted the results missed some published expectations and questioned lower product sales; an Hynix agreement remains unconfirmed.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves stronger-than-expected Q3 results and raised outlook, alongside a financing plan centered on customer prepayments rather than new unsecured debt, drove attention and optimism about AI-computing demand. Traders welcomed the update and speculated about short covering, while others argued that heavy debt, capital spending and continuing losses leave financing and profitability risks unresolved.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys expanding QNX partnerships are driving attention, particularly its integration into Valeos smart-camera platform, which has design wins with multiple automakers in China. Bulls view the wins as evidence of future growth in automotive software, while skeptics want to see design wins and the reported backlog convert into revenue.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

AMATs upcoming earnings and guidance are a key focus, with traders looking for evidence that AI-driven chipmaking investment is sustaining equipment orders. Bulls view the sector selloff as a buying opportunity, while bears question whether capex is being pulled forward and point to financing and export-policy risks.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas comments projecting weaker DefenCath reimbursement through 2027 after the TDAPA transition triggered a sharp selloff and dominate discussion. Traders are divided: bears worry about lower payments, slower uptake and competition from ClearGuard, while bulls argue DaVitas estimates are preliminary and point to CMSs $8.32 Q1 2027 add-on rate and the companys cash position; Medicare Advantage coverage remains a key uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

look at the cost analysis of this compared to amc or gme though. Im long here, and still green after doubling down on Friday right before close. &lt;7% of shares are profitable at this moment. It would appear most ogs either sold out to reposition post merger, or way overbought the hype.

@fasbal1 same thing happened on both amc and GME and a constant stream of traders posting things like you for weeks, in amc’s case, it went on for months before it happened… when amc dropped from $6 to $3 it was a hard choice for me to buy more… I didn’t buy those when they were getting hammered because I thought they would squeeze… I saw long term value… same thing with $MMAT… but I do hope all you people with higher averages looking for a squeeze get that fast turn around pay day, since I’ll also cash out on it and then re-enter with an even bigger position when it calms down.

StockTwits for iOS

Meta Materials Inc

Sudo Nim

StockTwits Web

look at the cost analysis of this compared to amc or gme though. Im long here, and still green after doubling down on Friday right before close. <7% of shares are profitable at this moment. It would appear most ogs either sold out to reposition post merger, or way overbought the hype.

Joel Sanders

@Khelevaster when GME was at $5 bears were saying it was the next blockbuster, bleeding money, closing stores, leases rising, no ability to compete online, it was endless… with amc, they were pointing out the debt, bankruptcy, their inability to weather the pandemic and on and on… when you say something like “cost analysis”, what specifically are you measuring/comparing? Are you talking about market cap? Growth stocks will never be comparable in that sense and a determination of value needs to be done differently because they will always seem more expensive. I see rapid growth based on their known IP, contracts, and their overall platform. From every angle I’ve researched, I see $MMAT building a strong foundation for their business at every step.

 when GME was at $5 bears were saying it was the next blockbuster, bleeding money, closing stores, leases rising, no ability to compete online, it was endless… with amc, they were pointing out the debt, bankruptcy, their inability to weather the pandemic and on and on… when you say something like “cost analysis”, what specifically are you measuring/comparing? Are you talking about market cap? Growth stocks will never be comparable in that sense and a determination of value needs to be done differently because they will always seem more expensive. I see rapid growth based on their known IP, contracts, and their overall platform. From every angle I’ve researched, I see 

 building a strong foundation for their business at every step.

 i don&#39;t agree with any of your assessment, I&#39;m long, been holding/accumulating since January. Sold in the 4.30s and repositioned in March. I believe in what meta is capable of. 

The cost analysis i am speaking too is the % of shares currently profitable to the holders. 6.83% here, 79% in amc and gme. This leads me to believe that most longs sold out to reposition post merger. If I can see that, shorts can see that. I see this dragging on for a bit and many squeeze chasers washing out.

 i don't agree with any of your assessment, I'm long, been holding/accumulating since January. Sold in the 4.30s and repositioned in March. I believe in what meta is capable of. 

The cost analysis i am speaking too is the % of shares currently profitable to the holders. 6.83% here, 79% in amc and gme. This leads me to believe that most longs sold out to reposition post merger. If I can see that, shorts can see that. I see this dragging on for a bit and many squeeze chasers washing out.

@Khelevaster amc and gme are already deep into their squeeze battles, so yes more positions would be profitable considering what has happened so far… but what if you compared $MMAT to amc the week of February 8th? While rallying and hitting $20, the board was being bombarded with people calling it a GME distraction, it dropped below $6 and then in March when it seemed to be turning around, the offering brought it right back to sub-$10… your ‘cost analysis’ (I really don’t think that’s the right term) would have suggested not to buy then either… it seems like you’re saying buy only once lots of people already made lots of money already in their positions and are holding?

 amc and gme are already deep into their squeeze battles, so yes more positions would be profitable considering what has happened so far… but what if you compared 

 to amc the week of February 8th? While rallying and hitting $20, the board was being bombarded with people calling it a GME distraction, it dropped below $6 and then in March when it seemed to be turning around, the offering brought it right back to sub-$10… your ‘cost analysis’ (I really don’t think that’s the right term) would have suggested not to buy then either… it seems like you’re saying buy only once lots of people already made lots of money already in their positions and are holding?

@halcyonandon fair points, that i had not even considered. I concede my argument entirely on that note. I suppose I&#39;m just skeptical about seeing a squeeze here. If it does I will certainly be forced into some tough decisions.

 fair points, that i had not even considered. I concede my argument entirely on that note. I suppose I'm just skeptical about seeing a squeeze here. If it does I will certainly be forced into some tough decisions.